Old Web
English
Sign In
Acemap
>
authorDetail
>
Claudio E. Rodriguez
Claudio E. Rodriguez
Ethicon Inc.
Medicine
Alemtuzumab
Adjustable gastric band
Body mass index
Diabetes mellitus
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies:
2019
Multiple Sclerosis Journal
Giancarlo Comi
Raed Alroughani
Aaron Boster
Ann D Bass
Regina Berkovich
Oscar Fernández
Ho Jin Kim
Volker Limmroth
Jan Lycke
Richard A.L. Macdonell
Basil Sharrack
Barry Singer
Patrick Vermersch
Heinz Wiendl
Tjalf Ziemssen
Alan Jacobs
Nadia Daizadeh
Claudio E. Rodriguez
Anthony Traboulsee
Show All
Source
Cite
Save
Citations (13)
Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study)
2018
Bart Van Wijmeersch
D Barone
Simon Broadley
Dominique Dive
Raymond Hupperts
Jan Lycke
Luca Massacesi
Xavier Montalban
Robert T. Naismith
K Pandey
Sven Schippling
P. Vermersch
Luke Chung
Nadia Daizadeh
Claudio E. Rodriguez
Kunio Nakamura
Heinz Wiendl
Show All
Source
Cite
Save
Citations (0)
Clinical outcomes of the REALIZE adjustable gastric band-C at one year in a U.S. population
2012
Surgery for Obesity and Related Diseases
Scott A. Cunneen
Collin E. Brathwaite
Christopher Joyce
Keith S. Gersin
Keith Kim
Jon L. Schram
Erik B. Wilson
Claudio E. Rodriguez
Mario Gutierrez
Show All
Source
Cite
Save
Citations (3)
1